Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
3,303
-164
-5% -$58.5K 0.47% 51
2025
Q4
$1.13M Sell
3,467
-28
-0.8% -$8.88K 0.45% 52
2025
Q3
$986K Sell
3,495
-365
-9% -$106K 0.4% 54
2025
Q2
$1.08M Sell
3,860
-8
-0.2% -$2.27K 0.48% 54
2025
Q1
$1.21M Buy
3,868
+51
+1% +$15.1K 0.54% 47
2024
Q4
$995K Buy
+3,817
New +$1.13M 0.44% 54

Other funds holding AMGN

ANB Bank's AMGN Position: Q1 2026 in Review

ANB Bank reduced its Amgen (AMGN) stake by 4.7% in Q1 2026, selling an estimated $58.5K and leaving 3,303 shares worth $1.16M. The position accounts for 0.47% of the portfolio, ranked #51.

ANB Bank first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.21M in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • ANB Bank held 3,303 shares of Amgen worth $1.16M as of Q1 2026.
  • ANB Bank sold 164 Amgen shares in Q1 2026, an estimated $58.5K.
  • Amgen made up 0.47% of ANB Bank's portfolio in Q1 2026, its #51 holding.
  • ANB Bank first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • ANB Bank's Amgen position peaked at $1.21M in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ANB Bank's 13F filing for Q1 2026, filed 6 May 2026.